Working Group Meeting, February 7-8, 2011 Agenda
This website is archived for historical purposes and is no longer being maintained or updated.
Atlanta, Georgia
Monday, February 7 | ||
---|---|---|
Time | Activity | Speaker |
8:30 | Closed Session called to order | Ned Calonge, Chair |
8:30– 8:45 | Welcome and Opening Statement | Ned Calonge |
8:45 – 9:15 | CDC, OPHG, and EGAPP | Muin Khoury |
9:15 - 10:00 | CDC, OPHG, and EGAPP Working Group Discussion | Ned Calonge |
10:00 - 10:15 | Break | |
10:15 - 10:30 | Status updates and review of briefing book materials | Dave Dotson |
10:30 - 11:45 | EGAPP Working Group and Project Planning | Ned Calonge, Muin Khoury, Ralph Coates, Evelyn Whitlock |
11:45 - 12:00 | Pick Up Lunch | |
12:15 - 1:00 | Lunch | |
1:00 - 1:45 | Type 2 Diabetes Report | Glenn Palomaki |
1:45 - 2:45 | KRAS and Colorectal Cancer Report Evidence-based analysis and policy guidance. Economic analysis |
Margie Parthimos Leslie LevinMbr/> Luciano Teraci |
2:45 - 2:55 | Break | |
>2:55 - 3:40 | BRAF & Colorectal Cancer | Jennifer Lin |
3:40 - 3:45 | Room Change | |
3:45 - 5:20 | Breakout Session 1: Type 2 Diabetes Recommendation | TEP Representative |
Breakout Session 2: KRAS/BRAF CRC Consideration of a Recommendation | TEP Representative | |
5:20 - 5:30 | Wrap-up and Adjourn CLOSED SESSION | Ned Calonge |
Tuesday, February 8 | ||
---|---|---|
Time | Activity | Speaker |
8:00 | Closed Session called to order | Ned Calonge |
8:00 -8:15 | Overview of Day 1 | Ned Calonge & Staff |
8:15 – 9:30 | Report and Discussion: KRAS/BRAC CRC Recommendation | TEP Representative |
9:30 – 10:00 | EGAPP Evaluation Report | Dave Dotson |
10:00 – 10:30 | Break | |
10:30 – 11:45 | Report and Discussion: Type 2 Diabetes Recommendation | TEP Representative |
11:45 – 12:00 | Fecal DNA brief in PLOS Currents EGT Fecal | Stephanie Melillo |
12:00 – 12:15 | DNA technical brief update | Evelyn Whitlock |
12:15 - 1:30 | Lunch | |
1:30 – 2:00 | Wrap Up and Action Items | Ned Calonge & Staff |
2:00 | Adjourn CLOSED SESSION | Ned Calonge |
- Page last reviewed: October 12, 2013 (archived document)
- Content source:
- Centers for Disease Control and Prevention
- Page maintained by: Office of Associate Director of Communication, Division of Public Affairs